Accuracy of cytology in sub typing non small cell lung carcinomas
Authors:
- 21 April 2017
- journal article
- research article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 45 (7) , 598-603
Abstract
Background: Sub typing of non small cell lung carcinoma (NSCLC) has an important task in the era of molecular and targeted therapies. Differentiating between squamous cell carcinoma (SQCC) and adenocarcinoma (ADC) is challenging when limited material is available in lung carcinoma. We investigated the accuracy and feasibility of sub typing NSCLCs in cytology and small biopsy material.Methods: Concurrent cytology and biopsy material obtained in a single CT‐ guided procedure in lung carcinoma over a year period retrospectively. Both materials were individually sub typed and analyzed. Immunohistochemistry (IHC) was performed. Accuracy was determined by comparing the results with IHC.Results: Total 107 of 126 cases of NSCLCs were included for analysis, where both cytology and biopsy material were adequate for interpretation. FNAC allowed tumor typing in 83 (77.6%) cases; 36 (33.6%) were ADC, 47 (43.9%) cases were SQCC and 24 (22.4%) cases diagnosed as Non‐small cell carcinoma not otherwise specified (NSCLC‐NOS). In biopsy, 86 cases (80.4%) were typed, among which 34 (31.8%) were ADC, 52 (48.6%) were SQCC and 21 (19.6%) were of NSCLC‐NOS type. The result of Chi‐square index was significant. With the aid of IHC, NSCLC‐NOS reduced from 14 (13%) cases to 2 (1.9%) cases.Conclusion: Cytology and small biopsy specimens achieved comparable specificity and accuracy in sub‐typing NSCLC and optimal results were obtain when findings from both modalities combine. The advantage of paired specimens is to maximize overall diagnostic yield and the remaining material will be available for ancillary technique like IHC or for molecular testing. Diagn. Cytopathol. 2017;45:598–603.Keywords
This publication has 23 references indexed in Scilit:
- Accuracy of Fine Needle Aspiration Cytology in the Pathological Typing of Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- The National Lung Screening Trial: Overview and Study DesignRadiology, 2011
- Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation AnalysisJournal of Thoracic Oncology, 2010
- Review Article: A Reevaluation of the Clinical Significance of Histological Subtyping of Non—Small-Cell Lung Carcinoma: Diagnostic Algorithms in the Era of Personalized TreatmentsInternational Journal of Surgical Pathology, 2009
- The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III StudiesThe Oncologist, 2009
- Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine‐needle aspiration specimensDiagnostic Cytopathology, 2009
- Bevacizumab in Non–Small Cell Lung CancerClinical Cancer Research, 2007
- Pathology of small cell carcinoma of the lungSeminars in Oncology, 2003
- Cytologic Features Useful for Distinguishing Small Cell From Non–Small Cell Carcinoma in Bronchial Brush and Wash SpecimensAmerican Journal of Clinical Pathology, 2000
- Bronchial brushing and bronchial biopsy: comparison of diagnostic accuracy and cell typing reliability in lung cancer.Thorax, 1986